Vaccine induced thrombotic thrombocytopenia: The shady chapter of a success story.
Metabol Open
; 11: 100101, 2021 Sep.
Article
em En
| MEDLINE
| ID: mdl-34179744
Adenoviral vector; Adenovirus; CAR, Coxsackie-adenovirus receptor; CDC, Centers for Disease Control and Prevention; COVID-19; COVID-19, Coronavirus disease 2019; CVST, cerebellar sinus thrombosis; FDA, Food and Drug Administration; HIT, Heparin-induced thrombocytopenia; ICU, Intensive Care Unit; IVIG, Intravenous immunoglobulin; LMWH, low molecular weight heparin; PF4, Platelet factor 4; PLT, Platelet; PRAC, Pharmacovigilance Risk Assessment Committee; PT, prothrombin time; SARS-CoV-2; SARS-Cov-2, severe acute respiratory syndrome coronavirus 2; SVT, splanchnic vein thrombosis; TTS, thrombosis-thrombocytopenia-syndrome; VCAM-1, vascular cell adhesion molecule 1; VIPIT, vaccine-induced prothrombotic immune thrombocytopenia; VITT, vaccine induced thrombotic thrombocytopenia; Vaccine; Vaccine induced thrombotic thrombocytopenia; aPTT, activated partial thromboplastin time; ΕΜΑ, European Medicines Agency
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Guideline
/
Risk_factors_studies
Idioma:
En
Revista:
Metabol Open
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
Grécia